2022 US Pharma

U.S. Pharma Companies Rankings using Artificial Intelligence

Top rated118 of 475
Best rating692\u2009%
Worst rating-5,863\u2009%
New companies117
Negative Economic Capital Ratio82 of 475

Chemomab Therapeutics Ltd. climbed 286 positions from 321 to 35 due it’s excellent Assets, Current. Minerva Neurosciences Inc. lost 380 positions from 25 to 405 due it’s bad Assets, Current. Tyra Biosciences Inc. entered the 2022 ranking at rank 3, making it the best newcomer.

Revenues441\u2009B
Assets1.09\u2009K
Expenses393\u2009B
Stockholders Equity585\u2009B
Unprofitable companies421 of 475

3. OMEROS CORP

506.44%

4. SYBLEU Inc

413.50%

5. uniQure N.V.

374.50%

9. Kaya Holdings Inc.

326.44%

14. Xencor Inc

241.62%

16. XOMA Corp

230.28%

17. PROCYON CORP

229.95%

18. Merck & Co. Inc.

226.21%

20. ABBOTT LABORATORIES

222.35%

21. Organon & Co.

219.56%

27. VERU INC.

193.67%

28. AbbVie Inc.

186.86%

31. Rebus Holdings Inc.

168.31%

35. XBiotech Inc.

161.62%

36. Lipocine Inc.

160.00%

37. Lifevantage Corp

153.75%

38. Zomedica Corp.

151.08%

41. ANAPTYSBIO INC

137.80%

45. EQRx Inc.

129.66%

50. PFIZER INC

121.44%

51. Royalty Pharma plc

121.10%

52. Sesen Bio Inc.

121.06%

56. Nuvation Bio Inc.

114.70%

57. Zoetis Inc.

113.46%

58. MEDICINOVA INC

111.65%

60. OPKO HEALTH INC.

107.76%

62. AMARIN CORP PLC\UK

104.18%

63. Catalent Inc.

103.46%

76. ELI LILLY & Co

83.89%

77. Nuvalent Inc.

82.58%

83. Shattuck Labs Inc.

70.91%

84. Alkermes plc.

69.71%

87. ESSA Pharma Inc.

63.24%

89. PERRIGO Co plc

59.33%

102. Adicet Bio Inc.

43.59%

104. Schrodinger Inc.

42.17%

107. Immuneering Corp

39.82%

111. Vaccitech plc

36.32%

115. Viatris Inc

34.96%

116. ALBIREO PHARMA INC.

34.88%

122. iBio Inc.

27.17%

124. LANDEC CORP CA

23.26%

126. BeiGene Ltd.

20.84%

127. MARIZYME INC

18.52%

134. Merus N.V.

13.20%

139. ARVINAS INC.

6.20%

142. Erasca Inc.

1.25%

154. Ainos Inc.

-12.80%

157. Savara Inc

-16.86%

159. NANOVIRICIDES INC.

-19.05%

161. NextCure Inc.

-22.21%

169. Mallinckrodt plc

-29.29%

172. IVERIC bio Inc.

-32.79%

179. Annovis Bio Inc.

-41.56%

182. IO Biotech Inc.

-42.53%

184. AYTU BIOPHARMA INC

-43.34%

186. LUMOS PHARMA INC.

-45.99%

187. Evolus Inc.

-46.17%

190. Nkarta Inc.

-49.66%

195. Cryoport Inc.

-53.79%

196. Acasti Pharma Inc.

-53.91%

197. Verona Pharma plc

-55.78%

198. ImmunoGen Inc.

-57.15%

199. Akouos Inc.

-58.86%

204. HARROW HEALTH INC.

-65.78%

214. Synaptogenix Inc.

-76.33%

216. ChemoCentryx Inc.

-78.35%

217. Orgenesis Inc.

-78.74%

220. Celularity Inc

-81.53%

223. SYNLOGIC INC.

-83.09%

228. CYTOKINETICS INC

-84.52%

229. Pulmatrix Inc.

-84.63%

231. Oncorus Inc.

-87.80%

232. SCYNEXIS INC

-88.76%

244. RenovoRx Inc.

-102.08%

247. MEI Pharma Inc.

-104.18%

249. Kronos Bio Inc.

-106.80%

251. Advaxis Inc.

-108.81%

253. DURECT CORP

-111.95%

254. Liquidia Corp

-112.28%

259. MANNKIND CORP

-131.24%

263. 2seventy bio Inc.

-136.61%

264. EYENOVIA INC.

-137.06%

265. Immunome Inc.

-139.88%

266. FIBROGEN INC

-140.28%

269. Altimmune Inc.

-146.80%

275. Genprex Inc.

-153.68%

277. Inozyme Pharma Inc.

-159.15%

281. Equillium Inc.

-163.12%

287. Novan Inc.

-167.89%

292. NEKTAR THERAPEUTICS

-177.91%

294. SOLIGENIX INC.

-181.45%

295. Radius Health Inc.

-182.81%

300. Rezolute Inc.

-189.97%

302. ZOGENIX INC.

-191.62%

308. OptiNose Inc.

-202.35%

310. GERON CORP

-204.43%

313. MUSTANG BIO INC.

-211.43%

314. Cue Biopharma Inc.

-211.76%

317. LANNETT CO INC

-215.89%

318. OTONOMY INC.

-216.18%

324. Zymeworks Inc.

-221.51%

325. Atreca Inc.

-223.05%

326. IMARA Inc.

-225.21%

328. Histogen Inc.

-225.82%

330. ORAGENICS INC

-231.22%

331. NexImmune Inc.

-232.99%

334. CohBar Inc.

-239.18%

336. Aravive Inc.

-241.04%

341. PLx Pharma Inc.

-256.72%

343. MACROGENICS INC

-258.60%

346. Zosano Pharma Corp

-267.14%

352. TREVENA INC

-292.25%

355. Biofrontera Inc.

-295.78%

356. Aptinyx Inc.

-295.79%

357. Verastem Inc.

-297.15%

363. IMMUNIC INC.

-304.06%

365. Athenex Inc.

-310.31%

368. GLYCOMIMETICS INC

-313.44%

373. MusclePharm Corp

-320.98%

376. Evoke Pharma Inc

-349.65%

379. CV Sciences Inc.

-63.63%

382. TherapeuticsMD Inc.

-371.27%

386. ONCOSEC MEDICAL Inc

-380.31%

387. UroGen Pharma Ltd.

-381.93%

392. Metacrine Inc.

-394.58%

394. Vaxxinity Inc.

-405.86%

397. EXICURE INC.

-418.67%

401. ABVC BIOPHARMA INC.

-440.35%

406. Epizyme Inc.

-449.66%

410. CytoDyn Inc.

-456.62%

411. Jaguar Health Inc.

-460.76%

419. ARDELYX INC.

-507.60%

421. Regen BioPharma Inc

-531.76%

426. CTI BIOPHARMA CORP

-557.57%

435. HST Global Inc.

-619.59%

439. Cell Source Inc.

-631.87%

441. ATHERSYS INC NEW

-710.51%

444. CANNAPHARMARX INC.

-762.19%

449. CEN BIOTECH INC

-848.36%

450. NEUROPATHIX INC.

-848.93%

457. CHIMERIX INC

-946.04%

458. Alzamend Neuro Inc.

-958.75%

462. Bioquest Corp

-1184.80%

463. HUMANIGEN INC

-1190.34%

464. Q BioMed Inc.

-1224.89%

465. BIOXYTRAN INC

-1286.97%

466. VACCINEX INC.

-1347.72%

467. Ocuphire Pharma Inc.

-1374.65%

468. Aditxt Inc.

-1529.95%

471. Scopus BioPharma Inc.

-1700.11%

472. ProtoKinetix Inc.

-3361.89%

474. BIOVIE INC.

-14858.80%

475. NEXIEN BIOPHARMA INC.

-23332.90%

All Ratings

United States Ratings

German Insurance Ratings